Illumina (XSWX:ILMN) Cyclically Adjusted Revenue per Share: CHF23.46 (As of Mar. 2026)


XSWX:ILMN Illumina Inc XSWX:ILMN
76 GF Score
Price CHF143.95
GF Value CHF105.51
! 7 Warning Signs
View Full Analysis

What is Illumina Cyclically Adjusted Revenue per Share?

Illumina XSWX:ILMN -0.79% 76 Cyclically Adjusted Revenue per Share is CHF23.46 as of Mar. 2026. GuruFocus rates XSWX:ILMN with a GF Score™ of 76/100 and a GF Value™ of CHF105.51. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Illumina's adjusted revenue per share for the three months ended in Mar. 2026 was CHF5.578. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CHF23.46 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Illumina's average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.20% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Illumina was 33.20% per year. The lowest was 7.50% per year. And the median was 17.85% per year.

As of today (2026-06-27), Illumina's current stock price is CHF143.95. Illumina's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was CHF23.46. Illumina's Cyclically Adjusted PS Ratio of today is 6.14.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Illumina was 29.44. The lowest was 2.57. And the median was 17.00.


Illumina  (XSWX:ILMN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Illumina's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=143.95/23.46
=6.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Illumina was 29.44. The lowest was 2.57. And the median was 17.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Illumina Cyclically Adjusted Revenue per Share Related Terms


Illumina Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Illumina's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Illumina Cyclically Adjusted Revenue per Share Chart

Illumina Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Illumina Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 23.46

XSWX:ILMN vs MTD, DGX, LH: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Illumina's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Illumina Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Illumina's Cyclically Adjusted PS Ratio falls into.


XSWX:ILMN
76GF Score
Illumina Inc XSWX:ILMN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Illumina Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Illumina's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.578/330.2130*330.2130
=5.578

Current CPI (Mar. 2026) = 330.2130.

Illumina Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.930 241.018 5.384
201609 3.991 241.428 5.459
201612 4.264 241.432 5.832
201703 4.074 243.801 5.518
201706 4.360 244.955 5.878
201709 4.643 246.819 6.212
201712 5.182 246.524 6.941
201803 5.009 249.554 6.628
201806 5.552 251.989 7.275
201809 5.543 252.439 7.251
201812 5.658 251.233 7.437
201903 5.681 254.202 7.380
201906 5.557 256.143 7.164
201909 6.071 256.759 7.808
201912 6.278 256.974 8.067
202003 5.568 258.115 7.123
202006 4.069 257.797 5.212
202009 4.908 260.280 6.227
202012 5.721 260.474 7.253
202103 6.913 264.877 8.618
202106 6.954 271.696 8.452
202109 6.683 274.310 8.045
202112 7.034 278.802 8.331
202203 7.149 287.504 8.211
202206 7.181 296.311 8.003
202209 6.912 296.808 7.690
202212 6.426 296.797 7.149
202303 6.367 301.836 6.966
202306 6.702 305.109 7.253
202309 6.371 307.789 6.835
202312 6.141 306.746 6.611
202403 6.013 312.332 6.357
202406 6.251 314.175 6.570
202409 5.719 315.301 5.989
202412 6.191 315.605 6.478
202503 5.785 319.799 5.973
202506 5.485 322.561 5.615
202509 5.604 324.800 5.697
202512 6.037 324.054 6.152
202603 5.578 330.213 5.578

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of CHF23.46 mean?
Illumina (XSWX:ILMN) has a Cyclically Adjusted Revenue per Share of CHF23.46 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Illumina and its competitors.
Is Illumina's Cyclically Adjusted Revenue per Share too high?
Illumina's current Cyclically Adjusted Revenue per Share is CHF23.46. Overall, Illumina has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Illumina's Cyclically Adjusted Revenue per Share compare to MTD and DGX?
Illumina's Cyclically Adjusted Revenue per Share of CHF23.46 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Illumina and its competitors. Illumina's current Cyclically Adjusted Revenue per Share is CHF23.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Illumina stock overvalued right now?
Illumina (XSWX:ILMN) has a current Cyclically Adjusted Revenue per Share of CHF23.46. The stock's GF Value™ is CHF105.51, compared to a current price of CHF143.95 — trading 36.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is CHF23.46. Illumina's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Illumina (XSWX:ILMN), the current Cyclically Adjusted Revenue per Share is CHF23.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Illumina (XSWX:ILMN) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of CHF143.95 is trading 36.4% above its estimated GF Value™ of CHF105.51.

Key valuation signals for XSWX:ILMN:

  • Cyclically Adjusted Revenue per Share: CHF23.46
  • GF Value™: CHF105.51 vs. price of CHF143.95 (36.4% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the XSWX:ILMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Illumina Business Description

Address 5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
76GF Score

Get the complete analysis for XSWX:ILMN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF143.95
Price
CHF105.51
GF Value